Bank of Montreal’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,718
| Closed | -$13K | – | 5203 |
|
|
2019
Q1 | $13K | Buy |
2,718
+2,339
| +617% | +$11.1K | ﹤0.01% | 3811 |
|
|
2018
Q4 | $1K | Sell |
379
-85,107
| -100% | -$591K | ﹤0.01% | 4624 |
|
|
2018
Q3 | $862K | Sell |
85,486
-81,705
| -49% | -$652K | ﹤0.01% | 2072 |
|
|
2018
Q2 | $1.21M | Buy |
167,191
+1,191
| +0.7% | +$8.3K | ﹤0.01% | 1910 |
|
|
2018
Q1 | $1M | Buy |
166,000
+95,884
| +137% | +$792K | ﹤0.01% | 1916 |
|
|
2017
Q4 | $674K | Buy |
70,116
+4,616
| +7% | +$30.2K | ﹤0.01% | 2145 |
|
|
2017
Q3 | $582K | Sell |
65,500
-5,804
| -8% | -$59.9K | ﹤0.01% | 2218 |
|
|
2017
Q2 | $902K | Buy |
71,304
+50,492
| +243% | +$598K | ﹤0.01% | 2031 |
|
|
2017
Q1 | $219K | Buy |
20,812
+14,212
| +215% | +$151K | ﹤0.01% | 2422 |
|
|
2016
Q4 | $78K | Sell |
6,600
-26,770
| -80% | -$302K | ﹤0.01% | 2952 |
|
|
2016
Q3 | $393K | Buy |
33,370
+9,896
| +42% | +$150K | ﹤0.01% | 2179 |
|
|
2016
Q2 | $304K | Sell |
23,474
-106,511
| -82% | -$1.55M | ﹤0.01% | 2278 |
|
|
2016
Q1 | $2.08M | Buy |
129,985
+63,339
| +95% | +$1.2M | ﹤0.01% | 1422 |
|
|
2015
Q4 | $1.91M | Buy |
66,646
+5,733
| +9% | +$159K | ﹤0.01% | 1423 |
|
|
2015
Q3 | $1.73M | Buy |
60,913
+1,133
| +2% | +$41.7K | ﹤0.01% | 1357 |
|
|
2015
Q2 | $2.15M | Buy |
59,780
+3,832
| +7% | +$119K | ﹤0.01% | 1355 |
|
|
2015
Q1 | $1.63M | Sell |
55,948
-1,158
| -2% | -$30.6K | ﹤0.01% | 1439 |
|
|
2014
Q4 | $1.2M | Buy |
57,106
+11,870
| +26% | +$235K | ﹤0.01% | 1619 |
|
|
2014
Q3 | $877K | Sell |
45,236
-504
| -1% | -$7.91K | ﹤0.01% | 1822 |
|
|
2014
Q2 | $714K | Buy |
45,740
+33,702
| +280% | +$545K | ﹤0.01% | 1910 |
|
|
2014
Q1 | $249K | Buy |
12,038
+3,038
| +34% | +$60.2K | ﹤0.01% | 2412 |
|
|
2013
Q4 | $116K | Hold |
9,000
| – | – | ﹤0.01% | 2481 |
|
|
2013
Q3 | $105K | Hold |
9,000
| – | – | ﹤0.01% | 2490 |
|
|
2013
Q2 | $42K | Buy |
+9,000
| New | +$33K | ﹤0.01% | 2790 |
|
Other funds holding INSY
WS
Bank of Montreal's INSY Position: Q2 2019 in Review
Bank of Montreal sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,718 shares — an estimated $13K sold.
Bank of Montreal first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $2.15M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Bank of Montreal reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of Montreal sold 2,718 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $13K.
- Bank of Montreal first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Bank of Montreal's Insys Therapeutics, Inc. position peaked at $2.15M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.